These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 16730775)

  • 21. C57Bl/6 mice are protected from respiratory syncytial virus (RSV) challenge and IL-5 associated pulmonary eosinophilic infiltrates following intranasal immunization with Protollin-eRSV vaccine.
    Cyr SL; Jones T; Stoica-Popescu I; Burt D; Ward BJ
    Vaccine; 2007 Apr; 25(16):3228-32. PubMed ID: 17374422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of dietary bovine colostrum on respiratory syncytial virus infection and immune responses following the infection in the mouse.
    Xu ML; Kim HJ; Wi GR; Kim HJ
    J Microbiol; 2015 Sep; 53(9):661-6. PubMed ID: 26310306
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Characterization of CD8+ T cell repertoire diversity and persistence in the influenza A virus model of localized, transient infection.
    Turner SJ; Kedzierska K; La Gruta NL; Webby R; Doherty PC
    Semin Immunol; 2004 Jun; 16(3):179-84. PubMed ID: 15130502
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of minimal CD8+ and CD4+ T cell epitopes in the Plasmodium yoelii hepatocyte erythrocyte protein 17kDa.
    Dobaño C; Doolan DL
    Mol Immunol; 2007 Apr; 44(11):3037-48. PubMed ID: 17303242
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased bacterial clearance from the lungs of mice following primary respiratory syncytial virus infection.
    Stark JM; Stark MA; Colasurdo GN; LeVine AM
    J Med Virol; 2006 Jun; 78(6):829-38. PubMed ID: 16628585
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic delivery of an anti-RSV antibody to protect against pulmonary infection with RSV.
    Skaricic D; Traube C; De B; Joh J; Boyer J; Crystal RG; Worgall S
    Virology; 2008 Aug; 378(1):79-85. PubMed ID: 18556039
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Type 1 and 2 immunity following vaccination is influenced by nanoparticle size: formulation of a model vaccine for respiratory syncytial virus.
    Mottram PL; Leong D; Crimeen-Irwin B; Gloster S; Xiang SD; Meanger J; Ghildyal R; Vardaxis N; Plebanski M
    Mol Pharm; 2007; 4(1):73-84. PubMed ID: 17274665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. IL-9 regulates pathology during primary and memory responses to respiratory syncytial virus infection.
    Dodd JS; Lum E; Goulding J; Muir R; Van Snick J; Openshaw PJ
    J Immunol; 2009 Dec; 183(11):7006-13. PubMed ID: 19915054
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mutating the anchor residues associated with MHC binding inhibits and deviates CD8+ T cell mediated protective immunity against malaria.
    Dobaño C; McTague A; Sette A; Hoffman SL; Rogers WO; Doolan DL
    Mol Immunol; 2007 Mar; 44(9):2235-48. PubMed ID: 17169429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Elevated frequencies of self-reactive CD8+ T cells following immunization with a xenoantigen are due to the presence of a heteroclitic CD4+ T-cell helper epitope.
    Kianizad K; Marshall LA; Grinshtein N; Bernard D; Margl R; Cheng S; Beermann F; Wan Y; Bramson J
    Cancer Res; 2007 Jul; 67(13):6459-67. PubMed ID: 17616707
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determining the breadth of the respiratory syncytial virus-specific T cell response.
    McDermott DS; Knudson CJ; Varga SM
    J Virol; 2014 Mar; 88(6):3135-43. PubMed ID: 24371055
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung.
    de Bree GJ; Daniels H; Schilfgaarde Mv; Jansen HM; Out TA; van Lier RA; Jonkers RE
    J Infect Dis; 2007 Jun; 195(11):1718-25. PubMed ID: 17471443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HLA-DP4 presents an immunodominant peptide from the RSV G protein to CD4 T cells.
    de Graaff PM; Heidema J; Poelen MC; van Dijk ME; Lukens MV; van Gestel SP; Reinders J; Rozemuller E; Tilanus M; Hoogerhout P; van Els CA; van der Most RG; Kimpen JL; van Bleek GM
    Virology; 2004 Sep; 326(2):220-30. PubMed ID: 15302208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. RSV-induced immunopathology: dynamic interplay between the virus and host immune response.
    Varga SM; Braciale TJ
    Virology; 2002 Apr; 295(2):203-7. PubMed ID: 12033778
    [No Abstract]   [Full Text] [Related]  

  • 35. Differential role of IL-2R signaling for CD8+ T cell responses in acute and chronic viral infections.
    Bachmann MF; Wolint P; Walton S; Schwarz K; Oxenius A
    Eur J Immunol; 2007 Jun; 37(6):1502-12. PubMed ID: 17492805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quality and vaccine efficacy of CD4+ T cell responses directed to dominant and subdominant epitopes in ESAT-6 from Mycobacterium tuberculosis.
    Aagaard CS; Hoang TT; Vingsbo-Lundberg C; Dietrich J; Andersen P
    J Immunol; 2009 Aug; 183(4):2659-68. PubMed ID: 19620314
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis B virus splice-generated protein induces T-cell responses in HLA-transgenic mice and hepatitis B virus-infected patients.
    Mancini-Bourgine M; Bayard F; Soussan P; Deng Q; Lone YC; Kremsdorf D; Michel ML
    J Virol; 2007 May; 81(10):4963-72. PubMed ID: 17360751
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional impairment of cytotoxic T cells in the lung airways following respiratory virus infections.
    Vallbracht S; Unsöld H; Ehl S
    Eur J Immunol; 2006 Jun; 36(6):1434-42. PubMed ID: 16708402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of the binding of monoclonal and polyclonal antibodies to the glycoproteins of antigenic variants of human respiratory syncytial virus by surface plasmon resonance.
    McGill A; Marsh R; Craft AW; Toms GL
    J Immunol Methods; 2005 Feb; 297(1-2):143-52. PubMed ID: 15777938
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative effects of palivizumab and donor-derived T cells on chronic respiratory syncytial virus infection, lung disease, and fusion glycoprotein amino acid sequences in a patient before and after bone marrow transplantation.
    El Saleeby CM; Suzich J; Conley ME; DeVincenzo JP
    Clin Infect Dis; 2004 Jul; 39(2):e17-20. PubMed ID: 15307047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.